Standard
HIV-1 control
near MUC22 · rs9262632
Stands on its own.
Nothing else here links to this position yet — but the page above is the point: what the
research found, what each genotype means, and where it came from, in language you can
read. Links to conditions, drugs and the senses appear automatically if we write them.
What each result means
A/A
Published research associates this genotype with typical/baseline likelihood of HIV-1 control — no copies of the reported risk allele. (GWAS Catalog, Science 2010, PMID:21051598)
A/G
Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with HIV-1 control. (GWAS Catalog, Science 2010, PMID:21051598)
G/G
Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of HIV-1 control compared to the general population. (GWAS Catalog, Science 2010, PMID:21051598)
Source
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F,
Jia X,
McLaren PJ,
Telenti A,
de Bakker PI,
Walker BD,
Ripke S,
Brumme CJ,
Pulit SL,
Carrington M,
Kadie CM,
Carlson JM
and 326 more — show all
Heckerman D,
Graham RR,
Plenge RM,
Deeks SG,
Gianniny L,
Crawford G,
Sullivan J,
Gonzalez E,
Davies L,
Camargo A,
Moore JM,
Beattie N,
Gupta S,
Crenshaw A,
Burtt NP,
Guiducci C,
Gupta N,
Gao X,
Qi Y,
Yuki Y,
Piechocka-Trocha A,
Cutrell E,
Rosenberg R,
Moss KL,
Lemay P,
O'Leary J,
Schaefer T,
Verma P,
Toth I,
Block B,
Baker B,
Rothchild A,
Lian J,
Proudfoot J,
Alvino DM,
Vine S,
Addo MM,
Allen TM,
Altfeld M,
Henn MR,
Le Gall S,
Streeck H,
Haas DW,
Kuritzkes DR,
Robbins GK,
Shafer RW,
Gulick RM,
Shikuma CM,
Haubrich R,
Riddler S,
Sax PE,
Daar ES,
Ribaudo HJ,
Agan B,
Agarwal S,
Ahern RL,
Allen BL,
Altidor S,
Altschuler EL,
Ambardar S,
Anastos K,
Anderson B,
Anderson V,
Andrady U,
Antoniskis D,
Bangsberg D,
Barbaro D,
Barrie W,
Bartczak J,
Barton S,
Basden P,
Basgoz N,
Bazner S,
Bellos NC,
Benson AM,
Berger J,
Bernard NF,
Bernard AM,
Birch C,
Bodner SJ,
Bolan RK,
Boudreaux ET,
Bradley M,
Braun JF,
Brndjar JE,
Brown SJ,
Brown K,
Brown ST,
Burack J,
Bush LM,
Cafaro V,
Campbell O,
Campbell J,
Carlson RH,
Carmichael JK,
Casey KK,
Cavacuiti C,
Celestin G,
Chambers ST,
Chez N,
Chirch LM,
Cimoch PJ,
Cohen D,
Cohn LE,
Conway B,
Cooper DA,
Cornelson B,
Cox DT,
Cristofano MV,
Cuchural G Jr,
Czartoski JL,
Dahman JM,
Daly JS,
Davis BT,
Davis K,
Davod SM,
DeJesus E,
Dietz CA,
Dunham E,
Dunn ME,
Ellerin TB,
Eron JJ,
Fangman JJ,
Farel CE,
Ferlazzo H,
Fidler S,
Fleenor-Ford A,
Frankel R,
Freedberg KA,
French NK,
Fuchs JD,
Fuller JD,
Gaberman J,
Gallant JE,
Gandhi RT,
Garcia E,
Garmon D,
Gathe JC Jr,
Gaultier CR,
Gebre W,
Gilman FD,
Gilson I,
Goepfert PA,
Gottlieb MS,
Goulston C,
Groger RK,
Gurley TD,
Haber S,
Hardwicke R,
Hardy WD,
Harrigan PR,
Hawkins TN,
Heath S,
Hecht FM,
Henry WK,
Hladek M,
Hoffman RP,
Horton JM,
Hsu RK,
Huhn GD,
Hunt P,
Hupert MJ,
Illeman ML,
Jaeger H,
Jellinger RM,
John M,
Johnson JA,
Johnson KL,
Johnson H,
Johnson K,
Joly J,
Jordan WC,
Kauffman CA,
Khanlou H,
Killian RK,
Kim AY,
Kim DD,
Kinder CA,
Kirchner JT,
Kogelman L,
Kojic EM,
Korthuis PT,
Kurisu W,
Kwon DS,
LaMar M,
Lampiris H,
Lanzafame M,
Lederman MM,
Lee DM,
Lee JM,
Lee MJ,
Lee ET,
Lemoine J,
Levy JA,
Llibre JM,
Liguori MA,
Little SJ,
Liu AY,
Lopez AJ,
Loutfy MR,
Loy D,
Mohammed DY,
Man A,
Mansour MK,
Marconi VC,
Markowitz M,
Marques R,
Martin JN,
Martin HL Jr,
Mayer KH,
McElrath MJ,
McGhee TA,
McGovern BH,
McGowan K,
McIntyre D,
Mcleod GX,
Menezes P,
Mesa G,
Metroka CE,
Meyer-Olson D,
Miller AO,
Montgomery K,
Mounzer KC,
Nagami EH,
Nagin I,
Nahass RG,
Nelson MO,
Nielsen C,
Norene DL,
O'Connor DH,
Ojikutu BO,
Okulicz J,
Oladehin OO,
Oldfield EC 3rd,
Olender SA,
Ostrowski M,
Owen WF Jr,
Pae E,
Parsonnet J,
Pavlatos AM,
Perlmutter AM,
Pierce MN,
Pincus JM,
Pisani L,
Price LJ,
Proia L,
Prokesch RC,
Pujet HC,
Ramgopal M,
Rathod A,
Rausch M,
Ravishankar J,
Rhame FS,
Richards CS,
Richman DD,
Rodes B,
Rodriguez M,
Rose RC 3rd,
Rosenberg ES,
Rosenthal D,
Ross PE,
Rubin DS,
Rumbaugh E,
Saenz L,
Salvaggio MR,
Sanchez WC,
Sanjana VM,
Santiago S,
Schmidt W,
Schuitemaker H,
Sestak PM,
Shalit P,
Shay W,
Shirvani VN,
Silebi VI,
Sizemore JM Jr,
Skolnik PR,
Sokol-Anderson M,
Sosman JM,
Stabile P,
Stapleton JT,
Starrett S,
Stein F,
Stellbrink HJ,
Sterman FL,
Stone VE,
Stone DR,
Tambussi G,
Taplitz RA,
Tedaldi EM,
Telenti A,
Theisen W,
Torres R,
Tosiello L,
Tremblay C,
Tribble MA,
Trinh PD,
Tsao A,
Ueda P,
Vaccaro A,
Valadas E,
Vanig TJ,
Vecino I,
Vega VM,
Veikley W,
Wade BH,
Walworth C,
Wanidworanun C,
Ward DJ,
Warner DA,
Weber RD,
Webster D,
Weis S,
Wheeler DA,
White DJ,
Wilkins E,
Winston A,
Wlodaver CG,
van't Wout A,
Wright DP,
Yang OO,
Yurdin DL,
Zabukovic BW,
Zachary KC,
Zeeman B,
Zhao M
Science (New York, N.Y.) · 2010 · PMID 21051598
Questions about rs9262632
What is rs9262632?
rs9262632 is a single position in the genome, in or near the near MUC22 gene. Published research associates it with hiv-1 control. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
Does having rs9262632 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs9262632 come from?
GWAS Catalog, Science 2010, PMID:21051598. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.
← See all variants